• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

MEDIFAST INC Common Stock (NY:MED)

13.08 +3.34 (+34.29%)
Official Closing Price Updated: 7:00 PM EDT, Aug 4, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about MEDIFAST INC Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
3 Out-of-Favor Stocks with Open Questions
March 10, 2026
The past year hasn't been kind to the stocks featured in this article. Each has tumbled to their lowest points in 12 months, leaving investors to decide whet... 
Via StockStory
News headline image
Medifast’s Q4 Earnings Call: Our Top 5 Analyst Questions
February 24, 2026
Medifast’s fourth quarter results outperformed Wall Street’s revenue expectations, which the market responded to positively. Management attributed this to early signs of success from its transition to... 
Via StockStory
Topics Earnings
News headline image
Scientific Evidence Demonstrates OPTAVIA®’s Metabolic Health Benefits, Opening the Door to Qualified HSA/FSA Clients
February 20, 2026
From Medifast
Via Business Wire
Medifast Inc (NYSE:MED) Reports Mixed Q4 Results with Deepening Losses and Challenging 2026 Outlook ↗
February 17, 2026
Via Chartmill
News headline image
MED Q4 Deep Dive: Metabolic Health Pivot Drives Early Coach Productivity Gains
February 18, 2026
Wellness company Medifast (NYSE:MED) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, but sales fell by 36.9% year on year to $75.1 million. On the other hand, next quarter’s revenue... 
Via StockStory
News headline image
Medifast (MED) Q4 2025 Earnings Call Transcript ↗
February 17, 2026
Medifast (MED) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Medifast’s (NYSE:MED) Q4 CY2025 Sales Top Estimates
February 17, 2026
Wellness company Medifast (NYSE:MED) reported Q4 CY2025 results exceeding the market’s revenue expectations, but sales fell by 36.9% year on year to $75.1 million. On the other hand, next quarter’s... 
Via StockStory
News headline image
Medifast Announces Fourth Quarter and Full Year 2025 Financial Results
February 17, 2026
From Medifast
Via Business Wire
News headline image
Earnings To Watch: Medifast (MED) Reports Q4 Results Tomorrow
February 15, 2026
Wellness company Medifast (NYSE:MED) will be reporting results this Tuesday after the bell. Here’s what to expect. 
Via StockStory
Topics Artificial Intelligence
News headline image
Medifast to Announce Financial Results for the Fourth Quarter and Full Year Ended December 31, 2025
February 03, 2026
From Medifast
Via Business Wire
News headline image
3 Stocks Under $50 We Approach with Caution
February 01, 2026
Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline prices don’t guarantee quality, and... 
Via StockStory
News headline image
1 of Wall Street’s Favorite Stock to Target This Week and 2 We Question
January 29, 2026
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional... 
Via StockStory
News headline image
3 Russell 2000 Stocks We’re Skeptical Of
January 20, 2026
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher... 
Via StockStory
News headline image
People Magazine Spotlights Tiffany Howard’s Metabolic Health Journey with OPTAVIA®
January 16, 2026
From Medifast
Via Business Wire
News headline image
OPTAVIA® Premieres Second Docuseries Episode “Health by Design: Spain” Exploring Metabolic Health and Longevity
January 15, 2026
From Medifast
Via Business Wire
News headline image
3 Reasons to Avoid MED and 1 Stock to Buy Instead
January 13, 2026
Over the past six months, Medifast’s stock price fell to $11.62. Shareholders have lost 18.9% of their capital, which is disappointing considering the S&P 500 has climbed by 11.3%. This might have... 
Via StockStory
Topics Stocks
News headline image
Medifast Announces Planned Leadership Transition
January 05, 2026
From Medifast
Via Business Wire
News headline image
1 Consumer Stock to Target This Week and 2 We Question
December 21, 2025
Consumer staples stocks are solid insurance policies in frothy markets ripe for corrections. But they’re also double-edged swords as they often lag in booming conditions, and this pattern has persisted... 
Via StockStory
Topics Stocks
News headline image
Q3 Earnings Highlights: Medifast (NYSE:MED) Vs The Rest Of The Personal Care Stocks
December 17, 2025
As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the personal care industry, including Medifast (NYSE:MED) and its peers. 
Via StockStory
Topics Economy
News headline image
OPTAVIA Survey Reveals 80% of Americans Lack Understanding of Metabolic Health Despite Its Major Impact to Overall Health and Wellbeing
December 09, 2025
From Medifast
Via Business Wire
News headline image
Why Medifast (MED) Stock Is Up Today
December 08, 2025
Shares of wellness company Medifast (NYSE:MED) jumped 3.6% in the afternoon session after reports highlighted a consensus analyst price target suggesting a potential upside of more than 51%. A survey... 
Via StockStory
Topics Economy
News headline image
3 Stocks Under $50 We’re Skeptical Of
December 02, 2025
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to... 
Via StockStory
News headline image
3 of Wall Street’s Favorite Stocks We Keep Off Our Radar
December 01, 2025
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional... 
Via StockStory
News headline image
3 Small-Cap Stocks That Fall Short
November 24, 2025
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a... 
Via StockStory
News headline image
3 Unprofitable Stocks That Fall Short
November 21, 2025
Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to convert spending into sustainable growth. 
Via StockStory
News headline image
Medifast Scientific & Clinical Affairs Team Showcases New Research in Metabolic Health at ObesityWeek Conference
November 13, 2025
From Medifast
Via Business Wire
News headline image
5 Insightful Analyst Questions From Medifast’s Q3 Earnings Call
November 10, 2025
Medifast’s third quarter results met Wall Street’s revenue expectations, but the market responded negatively as sales continued to decline sharply year-over-year. Management attributed these results to... 
Via StockStory
Topics Earnings
News headline image
MED Q3 Deep Dive: Focus Shifts to Metabolic Health Amid Industry Challenges
November 04, 2025
Wellness company Medifast (NYSE:MED) met Wall Streets revenue expectations in Q3 CY2025, but sales fell by 36.2% year on year to $89.41 million. On the other hand, next quarter’s revenue guidance of... 
Via StockStory
News headline image
Medifast (NYSE:MED) Posts Q3 Sales In Line With Estimates
November 03, 2025
Wellness company Medifast (NYSE:MED) met Wall Streets revenue expectations in Q3 CY2025, but sales fell by 36.2% year on year to $89.41 million. On the other hand, next quarter’s revenue guidance of... 
Via StockStory
Topics Artificial Intelligence
News headline image
Medifast Announces Third Quarter 2025 Financial Results
November 03, 2025
From Medifast
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap